REQUEST A DEMO
Total
USD $0.00
Search more companies

Korea Pharma Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Korea Pharma Co.,Ltd. Profile Updated: August 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Korea Pharma Co.,Ltd. is an enterprise based in South Korea. Its main office is in Hwaseong. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on December 24, 1985. Korea Pharma Co.,Ltd. currently employs 284 (2024) people. From the latest financial highlights, Korea Pharma Co.,Ltd. reported a net sales revenue increase of 2.49% in Q12025. A negative growth of 3.33% was recorded in its total assets. The enterprise’s net profit margin decreased by 4.01% in 2025.

Headquarters
87, Jeyakgongdan 3-Gil, Hyangnam-Eup
Hwaseong; Gyeonggi;

Contact Details: Purchase the Korea Pharma Co.,Ltd. report to view the information.

Website: http://koreapharma.co.kr

Basic Information
Total Employees:
Purchase the Korea Pharma Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Korea Pharma Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Korea Pharma Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Korea Pharma Co.,Ltd. report to view the information.
Incorporation Date:
December 24, 1985
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)한국파마
Company Performance
Financial values in the chart are available after Korea Pharma Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
2.49%
Total Operating Revenue
2.33%
Operating Profit
-42.95%
EBITDA
-32.53%
Net Profit/Loss for the Period
-60.91%
Total Assets
-3.33%
Total Equity
2.97%
Operating Profit Margin
-3.08%
Net Profit Margin
-4.01%
Return on Equity (ROE)
-1.18%
Debt / Equity
-11.56%
Quick Ratio
0.42%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?